Clinical application and evaluation of vancomycin dosing in adults

Journal of Pharmacy Technology

Volumn 17, Issue 2, 2001, Pages 33-38

  Rushing, T A ^a   Ambrose, P J ^a  

^a LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BODY WEIGHT; CREATININE CLEARANCE; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; RELIABILITY; STEADY STATE;

EID: 0035051744     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250101700201     Document Type: Article

References (25)

1. Pharmacokinetics of vancomycin in patients with various degrees of renal function
2. Vancomycin therapy in patients with impaired renal function: A nomogram for dosage
3. A simplified dosing method for initiating vancomycin therapy
4. Evaluation of a method of initiating vancomycin therapy: Experience in 205 patients
5. Routine monitoring of serum vancomycin concentrations: Can waiting be justified?
6. Outcome assessment of minimizing vancomycin monitoring and dosing adjustments
7. Serum vancomycin concentrations: Reappraisal of their clinical value
8. Monitoring serum vancomycin levels: Climbing the mountain because it is there?
9. Vancomycin therapeutic drug monitoring: Is it necessary?
10. Routine monitoring of serum vancomycin concentrations: Waiting for proof of its value
11. Mississippi mud in the 1990s: Risks and outcomes of vancomycin-associated toxicity in general oncology practice
12. Vancomycin pharmacokinetics in a patient population: Effect of age, gender, and body weight
13. Vancomycin pharmacokinetics in middle-aged and elderly men
14. Therapeutic drug monitoring of vancomycin in a morbidly obese patient
15. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique
16. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia
17. Prediction of creatinine clearance from serum creatinine
18. Kinetic model for gentamicin dosing with the use of individual patient parameters
19. Gentamicin therapy
20. Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients
21. Scientific commentary: Some suggestions for measuring predictive performance
22. Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics